Western Blotting

OG Omer Goldman
LA Lital N. Adler
EH Emma Hajaj
TC Tommaso Croese
ND Naama Darzi
SG Sivan Galai
HT Hila Tishler
YA Yarden Ariav
DL Dor Lavie
LF Liat Fellus-Alyagor
RO Roni Oren
YK Yuri Kuznetsov
ED Eyal David
RJ Rami Jaschek
CS Chani Stossel
OS Oded Singer
SM Sergey Malitsky
RB Renana Barak
RS Rony Seger
NE Neta Erez
IA Ido Amit
AT Amos Tanay
AS Ann Saada
TG Talia Golan
TR Tamar Rubinek
JL Joo Sang Lee
SB Shay Ben-Shachar
IW Ido Wolf
AE Ayelet Erez
ask Ask a question
Favorite

The tissues were ground and lysed in a RIPA lysis buffer (Sigma-Aldrich) containing 1% protease inhibitor cocktail (Calbiochem) and 1% phosphatase inhibitor cocktail (P5726, Sigma-Aldrich). Following centrifugation, the supernatant was collected and protein content was evaluated by the Bradford assay or a BCA Protein Assay Kit (Thermo Fisher Scientific, cat # 23225). Twenty to 50 μg from each sample under reducing conditions was loaded into each lane and separated by electrophoresis on a 10% SDS polyacrylamide gel. Following electrophoresis, proteins were transferred to Cellulose Nitrate membranes (Tamar). Nonspecific binding was blocked by incubation with TBST [10 mmol/L Tris-HCl (pH 8.0), 150 mmol/L NaCl, 0.1% Tween 20] containing 5% skim milk for 1 hour at room temperature (RT). Membranes were subsequently incubated with antibodies (Western blot antibodies list; Supplementary Table S3).

Antibody was detected using peroxidase-conjugated AffiniPure goat anti-rabbit IgG or goat anti-mouse IgG (Jackson ImmunoResearch) and enhanced chemiluminescence Western blotting detection reagents (EZ-Gel, Biological Industries). Gels were quantified by Gel Doc XR+ (Bio-Rad) and analyzed by ImageLab 5.1 software (Bio-Rad). The relative intensity of each band was calculated by dividing the specific band intensity by the value obtained from the loading control.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A